English
简体中文
Total: £ 56.28
Published Date: 2025-10-17 | Pages: 129 | Tables: 118 | Pharma & Healthcare
The global Gadoxetic Acid Disodium Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Gadoxetic acid disodium injection is an MRI contrast agent primarily used for the diagnosis and assessment of liver diseases, such as hepatocellular carcinoma and liver metastases.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gadoxetic Acid Disodium Injection leading manufacturers including Bayer, Brilliant Pharmaceutical, Kelun Pharmaceutical, CTTQ, etc., dominate supply; the top five capture approximately % of global revenue, with Bayer leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gadoxetic Acid Disodium Injection market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Bayer
Brilliant Pharmaceutical
Kelun Pharmaceutical
CTTQ
Segment by Type
Single Injection
Multiple Injection
Segment by Application
Hospital
Clinic
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Gadoxetic Acid Disodium Injection study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Gadoxetic Acid Disodium Injection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gadoxetic Acid Disodium Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Injection
1.2.3 Multiple Injection
1.3 Market Segmentation by Application
1.3.1 Global Gadoxetic Acid Disodium Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gadoxetic Acid Disodium Injection Revenue Estimates and Forecasts 2020-2031
2.2 Global Gadoxetic Acid Disodium Injection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Gadoxetic Acid Disodium Injection Sales Estimates and Forecasts 2020-2031
2.4 Global Gadoxetic Acid Disodium Injection Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Gadoxetic Acid Disodium Injection Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Gadoxetic Acid Disodium Injection Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single Injection Market Size by Manufacturers
3.5.2 Multiple Injection Market Size by Manufacturers
3.6 Global Gadoxetic Acid Disodium Injection Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gadoxetic Acid Disodium Injection Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Gadoxetic Acid Disodium Injection Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gadoxetic Acid Disodium Injection Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Gadoxetic Acid Disodium Injection Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Gadoxetic Acid Disodium Injection Sales and Revenue by Type (2020-2031)
6.4 North America Gadoxetic Acid Disodium Injection Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gadoxetic Acid Disodium Injection Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Gadoxetic Acid Disodium Injection Sales and Revenue by Type (2020-2031)
7.4 Europe Gadoxetic Acid Disodium Injection Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gadoxetic Acid Disodium Injection Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Gadoxetic Acid Disodium Injection Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Gadoxetic Acid Disodium Injection Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Gadoxetic Acid Disodium Injection Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Gadoxetic Acid Disodium Injection Sales and Revenue by Type (2020-2031)
9.4 Central and South America Gadoxetic Acid Disodium Injection Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gadoxetic Acid Disodium Injection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Gadoxetic Acid Disodium Injection Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Gadoxetic Acid Disodium Injection Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gadoxetic Acid Disodium Injection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Business Overview
11.1.3 Bayer Gadoxetic Acid Disodium Injection Product Models, Descriptions and Specifications
11.1.4 Bayer Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bayer Gadoxetic Acid Disodium Injection Sales by Product in 2024
11.1.6 Bayer Gadoxetic Acid Disodium Injection Sales by Application in 2024
11.1.7 Bayer Gadoxetic Acid Disodium Injection Sales by Geographic Area in 2024
11.1.8 Bayer Gadoxetic Acid Disodium Injection SWOT Analysis
11.1.9 Bayer Recent Developments
11.2 Brilliant Pharmaceutical
11.2.1 Brilliant Pharmaceutical Corporation Information
11.2.2 Brilliant Pharmaceutical Business Overview
11.2.3 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection Product Models, Descriptions and Specifications
11.2.4 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection Sales by Product in 2024
11.2.6 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection Sales by Application in 2024
11.2.7 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection Sales by Geographic Area in 2024
11.2.8 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection SWOT Analysis
11.2.9 Brilliant Pharmaceutical Recent Developments
11.3 Kelun Pharmaceutical
11.3.1 Kelun Pharmaceutical Corporation Information
11.3.2 Kelun Pharmaceutical Business Overview
11.3.3 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection Product Models, Descriptions and Specifications
11.3.4 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection Sales by Product in 2024
11.3.6 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection Sales by Application in 2024
11.3.7 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection Sales by Geographic Area in 2024
11.3.8 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection SWOT Analysis
11.3.9 Kelun Pharmaceutical Recent Developments
11.4 CTTQ
11.4.1 CTTQ Corporation Information
11.4.2 CTTQ Business Overview
11.4.3 CTTQ Gadoxetic Acid Disodium Injection Product Models, Descriptions and Specifications
11.4.4 CTTQ Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 CTTQ Gadoxetic Acid Disodium Injection Sales by Product in 2024
11.4.6 CTTQ Gadoxetic Acid Disodium Injection Sales by Application in 2024
11.4.7 CTTQ Gadoxetic Acid Disodium Injection Sales by Geographic Area in 2024
11.4.8 CTTQ Gadoxetic Acid Disodium Injection SWOT Analysis
11.4.9 CTTQ Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Gadoxetic Acid Disodium Injection Industry Chain
12.2 Gadoxetic Acid Disodium Injection Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Gadoxetic Acid Disodium Injection Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Gadoxetic Acid Disodium Injection Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gadoxetic Acid Disodium Injection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gadoxetic Acid Disodium Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Gadoxetic Acid Disodium Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gadoxetic Acid Disodium Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gadoxetic Acid Disodium Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gadoxetic Acid Disodium Injection Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gadoxetic Acid Disodium Injection Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Gadoxetic Acid Disodium Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Gadoxetic Acid Disodium Injection Sales by Region (2020-2025) & (Units)
Table 8. Global Gadoxetic Acid Disodium Injection Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Gadoxetic Acid Disodium Injection Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Gadoxetic Acid Disodium Injection Sales Share by Manufacturers (2020-2025)
Table 12. Global Gadoxetic Acid Disodium Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Gadoxetic Acid Disodium Injection Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Gadoxetic Acid Disodium Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadoxetic Acid Disodium Injection as of 2024)
Table 16. Global Gadoxetic Acid Disodium Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Gadoxetic Acid Disodium Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Gadoxetic Acid Disodium Injection Manufacturing Base and Headquarters
Table 19. Global Gadoxetic Acid Disodium Injection Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Gadoxetic Acid Disodium Injection Sales by Type (2020-2025) & (Units)
Table 23. Global Gadoxetic Acid Disodium Injection Sales by Type (2026-2031) & (Units)
Table 24. Global Gadoxetic Acid Disodium Injection Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Gadoxetic Acid Disodium Injection Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Gadoxetic Acid Disodium Injection ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Gadoxetic Acid Disodium Injection Sales by Application (2020-2025) & (Units)
Table 29. Global Gadoxetic Acid Disodium Injection Sales by Application (2026-2031) & (Units)
Table 30. Gadoxetic Acid Disodium Injection High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Gadoxetic Acid Disodium Injection Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Gadoxetic Acid Disodium Injection Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Gadoxetic Acid Disodium Injection ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Gadoxetic Acid Disodium Injection Growth Accelerators and Market Barriers
Table 37. North America Gadoxetic Acid Disodium Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Gadoxetic Acid Disodium Injection Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Gadoxetic Acid Disodium Injection Growth Accelerators and Market Barriers
Table 40. Europe Gadoxetic Acid Disodium Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Gadoxetic Acid Disodium Injection Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Gadoxetic Acid Disodium Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Gadoxetic Acid Disodium Injection Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Gadoxetic Acid Disodium Injection Growth Accelerators and Market Barriers
Table 45. Southeast Asia Gadoxetic Acid Disodium Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Gadoxetic Acid Disodium Injection Investment Opportunities and Key Challenges
Table 47. Central and South America Gadoxetic Acid Disodium Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Gadoxetic Acid Disodium Injection Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Gadoxetic Acid Disodium Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bayer Corporation Information
Table 51. Bayer Description and Major Businesses
Table 52. Bayer Product Models, Descriptions and Specifications
Table 53. Bayer Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Bayer Sales Value Proportion by Product in 2024
Table 55. Bayer Sales Value Proportion by Application in 2024
Table 56. Bayer Sales Value Proportion by Geographic Area in 2024
Table 57. Bayer Gadoxetic Acid Disodium Injection SWOT Analysis
Table 58. Bayer Recent Developments
Table 59. Brilliant Pharmaceutical Corporation Information
Table 60. Brilliant Pharmaceutical Description and Major Businesses
Table 61. Brilliant Pharmaceutical Product Models, Descriptions and Specifications
Table 62. Brilliant Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Brilliant Pharmaceutical Sales Value Proportion by Product in 2024
Table 64. Brilliant Pharmaceutical Sales Value Proportion by Application in 2024
Table 65. Brilliant Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 66. Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection SWOT Analysis
Table 67. Brilliant Pharmaceutical Recent Developments
Table 68. Kelun Pharmaceutical Corporation Information
Table 69. Kelun Pharmaceutical Description and Major Businesses
Table 70. Kelun Pharmaceutical Product Models, Descriptions and Specifications
Table 71. Kelun Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Kelun Pharmaceutical Sales Value Proportion by Product in 2024
Table 73. Kelun Pharmaceutical Sales Value Proportion by Application in 2024
Table 74. Kelun Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 75. Kelun Pharmaceutical Gadoxetic Acid Disodium Injection SWOT Analysis
Table 76. Kelun Pharmaceutical Recent Developments
Table 77. CTTQ Corporation Information
Table 78. CTTQ Description and Major Businesses
Table 79. CTTQ Product Models, Descriptions and Specifications
Table 80. CTTQ Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. CTTQ Sales Value Proportion by Product in 2024
Table 82. CTTQ Sales Value Proportion by Application in 2024
Table 83. CTTQ Sales Value Proportion by Geographic Area in 2024
Table 84. CTTQ Gadoxetic Acid Disodium Injection SWOT Analysis
Table 85. CTTQ Recent Developments
Table 86. Key Raw Materials Distribution
Table 87. Raw Materials Key Suppliers
Table 88. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 89. Milestones in Production Technology Evolution
Table 90. Distributors List
Table 91. Market Trends and Market Evolution
Table 92. Market Drivers and Opportunities
Table 93. Market Challenges, Risks, and Restraints
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Gadoxetic Acid Disodium Injection Product Picture
Figure 2. Global Gadoxetic Acid Disodium Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Single Injection Product Picture
Figure 4. Multiple Injection Product Picture
Figure 5. Global Gadoxetic Acid Disodium Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Gadoxetic Acid Disodium Injection Report Years Considered
Figure 10. Global Gadoxetic Acid Disodium Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 12. Global Gadoxetic Acid Disodium Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Gadoxetic Acid Disodium Injection Revenue Market Share by Region (2020-2031)
Figure 14. Global Gadoxetic Acid Disodium Injection Sales (2020-2031) & (Units)
Figure 15. Global Gadoxetic Acid Disodium Injection Sales (CAGR) by Region (2020-2031) (Units)
Figure 16. Global Gadoxetic Acid Disodium Injection Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Gadoxetic Acid Disodium Injection Sales Volume Market Share in 2024
Figure 18. Global Gadoxetic Acid Disodium Injection Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Single Injection Revenue Market Share by Manufacturer in 2024
Figure 21. Multiple Injection Revenue Market Share by Manufacturer in 2024
Figure 22. Global Gadoxetic Acid Disodium Injection Sales Market Share by Type (2020-2031)
Figure 23. Global Gadoxetic Acid Disodium Injection Revenue Market Share by Type (2020-2031)
Figure 24. Global Gadoxetic Acid Disodium Injection Sales Market Share by Application (2020-2031)
Figure 25. Global Gadoxetic Acid Disodium Injection Revenue Market Share by Application (2020-2031)
Figure 26. North America Gadoxetic Acid Disodium Injection Sales YoY (2020-2031) & (Units)
Figure 27. North America Gadoxetic Acid Disodium Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) in 2024
Figure 29. North America Gadoxetic Acid Disodium Injection Sales Volume (Units) by Type (2020- 2031)
Figure 30. North America Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Gadoxetic Acid Disodium Injection Sales Volume (Units) by Application (2020-2031)
Figure 32. North America Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Gadoxetic Acid Disodium Injection Sales YoY (2020-2031) & (Units)
Figure 37. Europe Gadoxetic Acid Disodium Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) in 2024
Figure 39. Europe Gadoxetic Acid Disodium Injection Sales Volume (Units) by Type (2020-2031)
Figure 40. Europe Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Gadoxetic Acid Disodium Injection Sales Volume (Units) by Application (2020-2031)
Figure 42. Europe Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 44. France Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Gadoxetic Acid Disodium Injection Sales YoY (2020-2031) & (Units)
Figure 49. Asia-Pacific Gadoxetic Acid Disodium Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Gadoxetic Acid Disodium Injection Sales Volume (Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Gadoxetic Acid Disodium Injection Sales Volume (Units) by Application (2020-2031)
Figure 54. Asia-Pacific Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 59. India Gadoxetic Acid Disodium Injection Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Gadoxetic Acid Disodium Injection Sales YoY (2020-2031) & (Units)
Figure 61. Central and South America Gadoxetic Acid Disodium Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Gadoxetic Acid Disodium Injection Sales Volume (Units) by Type (2021-2031)
Figure 64. Central and South America Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Gadoxetic Acid Disodium Injection Sales Volume (Units) by Application (2020-2031)
Figure 66. Central and South America Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Gadoxetic Acid Disodium Injection Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Gadoxetic Acid Disodium Injection Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Gadoxetic Acid Disodium Injection Sales YoY (2020-2031) & (Units)
Figure 70. Middle East and Africa Gadoxetic Acid Disodium Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Gadoxetic Acid Disodium Injection Sales Volume (Units) by Type (2021-2031)
Figure 73. South America Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Gadoxetic Acid Disodium Injection Sales Volume (Units) by Application (2020-2031)
Figure 75. Middle East and Africa Gadoxetic Acid Disodium Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Gadoxetic Acid Disodium Injection Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Gadoxetic Acid Disodium Injection Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Gadoxetic Acid Disodium Injection Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Gadoxetic Acid Disodium Injection Revenue (2020-2025) & (US$ Million)
Figure 80. Gadoxetic Acid Disodium Injection Industry Chain Mapping
Figure 81. Regional Gadoxetic Acid Disodium Injection Manufacturing Base Distribution (%)
Figure 82. Global Gadoxetic Acid Disodium Injection Production Market Share by Region (2020-2031)
Figure 83. Gadoxetic Acid Disodium Injection Production Process
Figure 84. Regional Gadoxetic Acid Disodium Injection Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
